FDA 483 - Medline Industries, Inc. - October 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Medline Industries, LP in Waukegan, IL, was inspected and received a Form 483 with five observations indicating significant deficiencies in their quality control unit, manufacturing processes, and facility maintenance. The inspection revealed repeated microbial contamination issues, inadequate investigations, poor aseptic practices by operators, and failures in cleaning procedures and facility repair, all posing a risk to drug product quality and purity. The firm failed to ensure CGMP compliance and address systemic quality issues.
ID · 575ed556-d563-416d-8fe6-8ce35e2cbb2d